Sign Up to like & get
recommendations!
1
Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-118229
Abstract: BACKGROUND Current molecular risk stratification of multiple myeloma (MM), based on the presence of t(4 ;14) and 17p deletion, cannot fully explain treatment outcome heterogeneity, as other features also predict prognosis. About 30% of genetic…
read more here.
Keywords:
cks1b;
cdkn2c loss;
ratio;
cks1b gains ... See more keywords